$0.420
-0.018 (-4.22%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
NRSN Prediction & Forecast by Similar Chart Analysis
Alphio's NRSN stock price prediction model matches the current Neurosense Therapeutics Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.42 (-0.47%). The 1-week path is $0.41 (-3.05%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Neurosense Therapeutics Ltd Stock?
Neurosense Therapeutics Ltd is currently not a strong buy due to its ongoing financial losses and compliance risks, despite some positive catalysts. The current price is $0.42, which is significantly below the analyst's target of $3, indicating potential upside. However, the company reported a net income loss of $2.15 million for Q3 2024, and it faces a Nasdaq compliance warning for trading below $1.00, which poses a risk to its listing status.
NRSN stock price ended at $0.42 on Friday, after losing -4.22%
Neurosense Therapeutics Ltd (NRSN) last closed at $0.4204, losing -4.22%. These facts feed the 1-day and 1-week NRSN price prediction above.
Forecast Drivers
Neurosense Therapeutics Ltd (NRSN) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches NRSN, ranked by similarity.
Seasonality analysis for NRSN
Historically the probability of a positive August return for NRSN is 30.16%. September offers the highest probability of a positive month at 90.24%, while August is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for NRSN
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $2.45 | $2.46 | $2.78 | +485.94% |
| Sep 2026 | $1.99 | $2.05 | $2.35 | +388.79% |
| Oct 2026 | $1.82 | $1.82 | $2.18 | +333.09% |
| Nov 2026 | $1.69 | $1.82 | $1.94 | +333.09% |
| Dec 2026 | $2.00 | $2.21 | $2.41 | +426.16% |
In 2026, Neurosense Therapeutics Ltd (NRSN) is projected to range from $1.69 to $2.78.
Neurosense Therapeutics Ltd 2026 monthly forecast
In Aug 2026, Neurosense Therapeutics Ltd is projected to average $2.46, with a low of $2.45 and high of $2.78.
In Sep 2026, Neurosense Therapeutics Ltd is projected to average $2.05, with a low of $1.99 and high of $2.35.
In Oct 2026, Neurosense Therapeutics Ltd is projected to average $1.82, with a low of $1.82 and high of $2.18.
In Nov 2026, Neurosense Therapeutics Ltd is projected to average $1.82, with a low of $1.69 and high of $1.94.
In Dec 2026, Neurosense Therapeutics Ltd is projected to average $2.21, with a low of $2.00 and high of $2.41.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.